8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

被引：248
|
作者：
Eckhardt, Matthias [1 ]
Langkop, Elke [1 ]
Mark, Michael [2 ]
Tadayyon, Mob [2 ]
Thomas, Leo [2 ]
Nar, Herbert [3 ]
Pfrengle, Waldemar [4 ]
Guth, Brian [5 ]
Lotz, Ralf [5 ]
Sieger, Peter [5 ]
Fuchs, Holger [6 ]
Himmelsbach, Frank [1 ]
机构：
[1] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Chem Res, D-88400 Biberach, Germany
[2] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Metab Dis Res, D-88400 Biberach, Germany
[3] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Lead Discovery, D-88400 Biberach, Germany
[4] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Chem Dev, D-88400 Biberach, Germany
[5] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Drug Discovery Support, D-88400 Biberach, Germany
[6] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Drug Metab & Pharmacokinect, D-88400 Biberach, Germany
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 26期
关键词：
D O I：
10.1021/jm701280z
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new chemical class of potent DPP-4 inhibitors structurally derived from the xanthine scaffold for the treatment of type 2 diabetes has been discovered and evaluated. Systematic structural variations have led to 1 (BI 1356), a highly potent, selective, long-acting, and orally active DPP-4 inhibitor that shows considerable blood glucose lowering in different animal species. 1 is currently undergoing clinical phase IIb trials and holds the potential for once-daily treatment of type 2 diabetics.
引用
收藏
页码：6450 / 6453
页数：4
相关论文
共 50 条
  • [21] The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)
    Pike, Kurt G.
    Barlaam, Bernard
    Cadogan, Elaine
    Campbell, Andrew
    Chen, Yingxue
    Colclough, Nicola
    Davies, Nichola L.
    de-Almeida, Camila
    Degorce, Sebastien L.
    Didelot, Myriam
    Dishington, Allan
    Ducray, Richard
    Durant, Stephen T.
    Hassall, Lorraine A.
    Holmes, Jane
    Hughes, Gareth D.
    MacFaul, Philip A.
    Mulholland, Keith R.
    McGuire, Thomas M.
    Ouvry, Gilles
    Pass, Martin
    Robb, Graeme
    Stratton, Natalie
    Wang, Zhenhua
    Wilson, Joanne
    Zhai, Baochang
    Zhao, Kang
    Al-Huniti, Nidal
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (09) : 3823 - 3841
  • [22] Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist
    Villetti, G.
    Pastore, F.
    Bergamaschi, M.
    Bassani, F.
    Bolzoni, P. T.
    Battipaglia, L.
    Amari, G.
    Rizzi, A.
    Delcanale, M.
    Volta, R.
    Cenacchi, V.
    Cacciani, F.
    Zaniboni, M.
    Berti, F.
    Rossoni, G.
    Harrison, S.
    Petrillo, P.
    Santoro, E.
    Scudellaro, R.
    Mannini, F.
    Geppetti, P. A.
    Razzetti, R.
    Patacchini, R.
    Civelli, M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (03): : 622 - 635
  • [23] Profile of a Highly Selective Quaternized Pyrrolidine Betaine αvβ6 Integrin Inhibitor-(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S and 1R,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective Methylation
    Barrett, Tim N.
    Taylor, Jonathan A.
    Barker, Daniel
    Procopiou, Panayiotis A.
    Thompson, James D. F.
    Barrett, John
    Le, Joelle
    Lynn, Sean M.
    Pogany, Peter
    Pratley, Cassie
    Pritchard, John M.
    Roper, James A.
    Rowedder, James E.
    Slack, Robert J.
    Vitulli, Giovanni
    Macdonald, Simon J. F.
    Kerr, William J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (16) : 7543 - 7556
  • [24] Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yObenzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor Related Orphan Receptor C2 Inverse Agonist
    Schnute, Mark E.
    Wennerstal, Mattias
    Alley, Jennifer
    Bengtsson, Martin
    Blinn, James R.
    Bolten, Charles W.
    Braden, Timothy
    Bonn, Tomas
    Carlsson, Bo
    Caspers, Nicole
    Chen, Ming
    Choi, Chulho
    Collis, Leon P.
    Crouse, Kimberly
    Farnegardh, Mathias
    Fennell, Kimberly F.
    Fish, Susan
    Flick, Andrew C.
    Goos-Nilsson, Annika
    Gullberg, Hjalmar
    Harris, Peter K.
    Heasley, Steven E.
    Hegen, Martin
    Hromockyj, Alexander E.
    Hu, Xiao
    Husman, Bolette
    Janosik, Tomasz
    Jones, Peter
    Kaila, Neelu
    Kallin, Elisabet
    Kauppi, Bjorn
    Kiefer, James R.
    Knafels, John
    Koehler, Konrad
    Kruger, Lars
    Kurumbail, Ravi G.
    Kyne, Robert E., Jr.
    Li, Wei
    Lofstedt, Joakim
    Long, Scott A.
    Menard, Carol A.
    Mente, Scot
    Messing, Dean
    Meyers, Marvin J.
    Napierata, Lee
    Noteberg, Daniel
    Nuhant, Philippe
    Pelc, Matthew J.
    Prinsen, Michael J.
    Rhonnstad, Patrik
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (23) : 10415 - 10439
  • [25] Discovery of (2S)-8[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors
    Pasquier, Benoit
    El-Ahmad, Youssef
    Filoche-Romme, Bruno
    Dureuil, Christine
    Fassy, Florence
    Abecassis, Pierre-Yves
    Mathieu, Magali
    Bertrand, Thomas
    Benard, Tsiala
    Barriere, Cedric
    El Batti, Samira
    Letallec, Jean-Philippe
    Sonnefraud, Veronique
    Brollo, Maurice
    Delbarre, Laurence
    Loyau, Veronique
    Pilorge, Fabienne
    Bertin, Luc
    Richepin, Patrick
    Arigon, Jerome
    Labrosse, Jean-Robert
    Clement, Jacques
    Durand, Florence
    Combet, Romain
    Perraut, Pierre
    Leroy, Vincent
    Gay, Frederic
    Lefrancois, Dominique
    Bretin, Francois
    Marquette, Jean-Pierre
    Michot, Nadine
    Caron, Anne
    Castell, Christelle
    Schio, Laurent
    McCort, Gary
    Goulaouic, Helene
    Garcia-Echeverria, Carlos
    Ronan, Baptiste
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 376 - 400
  • [26] Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
    Li, Hui
    Tatlock, John
    Linton, Angelica
    Gonzalez, Javier
    Jewell, Tanya
    Patel, Leena
    Ludlum, Sarah
    Drowns, Matthew
    Rahavendran, Sadayappan V.
    Skor, Heather
    Hunter, Robert
    Shi, Stephanie T.
    Herlihy, Koleen J.
    Parge, Hans
    Hickey, Michael
    Yu, Xiu
    Chau, Fannie
    Nonomiya, Jim
    Lewis, Cristina
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (05) : 1255 - 1258
  • [27] Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: A highly potent orally available CCR5 selective antagonist
    Nishizawa, Rena
    Nishiyama, Toshihiko
    Hisaichi, Katsuya
    Minamoto, Chiaki
    Murota, Masayuki
    Takaoka, Yoshikazu
    Nakai, Hisao
    Tada, Hideaki
    Sagawa, Kenji
    Shibayama, Shiro
    Fukushima, Daikichi
    Maeda, Kenji
    Mitsuya, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (13) : 4028 - 4042
  • [28] The Discovery of N-((2H-Tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist
    DeMong, Duane
    Dai, Xing
    Hwa, Joyce
    Miller, Michael
    Lin, Sue-Ing
    Kang, Ling
    Stamford, Andrew
    Greenlee, William
    Yu, Wensheng
    Wong, Michael
    Lavey, Brian
    Kozlowski, Joseph
    Zhou, Guowei
    Yang, De-Yi
    Patel, Bhuneshwari
    Soriano, Aileen
    Zhai, Ying
    Sondey, Christopher
    Zhang, Hongtao
    Lachowicz, Jean
    Grotz, Diane
    Cox, Kathleen
    Morrison, Richard
    Andreani, Teresa
    Cao, Yang
    Liang, Mark
    Meng, Tao
    McNamara, Paul
    Wong, Jesse
    Bradley, Prudence
    Feng, Kung-I
    Belani, Jitendra
    Chen, Ping
    Dai, Peng
    Gauuan, Jolicia
    Lin, Peishan
    Zhao, He
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2601 - 2610
  • [29] Discovery of a potent, selective, and orally bioavailable c-Met inhibitor:: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)
    Liu, Longbin
    Siegmund, Aaron
    Xi, Ning
    Kaplan-Lefko, Paula
    Rex, Karen
    Cheti, April
    Lin, Jasmine
    Moriguchi, Jodi
    Berry, Loren
    Huang, Liyue
    Teffera, Yohannes
    Yang, Yajing
    Zhang, Yihong
    Bellon, Steven F.
    Lee, Matthew
    Shimanovich, Roman
    Bak, Annette
    Dominguez, Celia
    Norman, Mark H.
    Harmange, Jean-Christophe
    Dussault, Isabelle
    Kimt, Tae-Seong
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3688 - 3691
  • [30] Discovery of N-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834):: A potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa
    Phillips, GB
    Buckman, BO
    Davey, DD
    Eagen, KA
    Guilford, WJ
    Hinchman, J
    Ho, E
    Koovakkat, S
    Liang, A
    Light, DR
    Mohan, R
    Ng, HP
    Post, JM
    Shaw, KJ
    Smith, D
    Subramanyam, B
    Sullivan, ME
    Trinh, L
    Vergona, R
    Walters, J
    White, K
    Whitlow, M
    Wu, S
    Xu, W
    Morrissey, MM
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (19) : 3557 - 3562
12345